What is bmiMD?
bmiMD (Personalized Health RX) is a US telehealth platform focused on weight management through compounded GLP-1 medications. The catalog centers on two molecules: compounded semaglutide (the same active ingredient as Wegovy and Ozempic) and compounded tirzepatide (the same active ingredient as Zepbound and Mounjaro). The platform packages these as an all-inclusive personalized program — meaning your subscription bundles the medication, telehealth physician access, and dietary guidance into a single price rather than charging separately for each piece.
As of 2026, bmiMD reports 80,000+ active members and a 4.9-star average rating on its own platform. We report these as published marketing data — we have no way to independently audit member counts or rating distributions on a private telehealth platform. What we can measure is conversion performance from our own affiliate dashboard: bmiMD's editorial conversion rate of 6.99% is the highest in our reviewed roster, meaningfully above the category average of roughly 3-5%. That tells us bmiMD's intake flow, landing page, and product-market fit are doing real work — visitors who arrive convert at a higher rate than peer platforms.
A note on affiliate-network categorization: bmiMD is currently catalogued under "Beauty & Cosmetics" inside the Katalys network, which is awkward — the product is metabolic medicine, not skincare. We flag this for transparency. It may reflect a Katalys taxonomy choice or bmiMD's broader brand positioning, and the brand may be in transition. The categorization does not change the medication being prescribed.
Pricing model — personalized, all-inclusive, no published hook
bmiMD does not publish a fixed entry price the way several competitors do. Embody is a flat $149/month. SkinnyRx is $179 for the first month. SHED is $199-$299/month tiered. bmiMD's pricing is personalized after the intake questionnaire — meaning you fill out the medical questionnaire first, and the platform quotes you a price based on the protocol assigned. There is no $99-first-month or $149-flat hook available pre-intake.
This is a trade-off, not a flaw. The upside: when you receive your quote, it is genuinely all-inclusive. Medication, telehealth consultation, and dietary guidance are bundled — there are no $40 consultation fees layered on later, no $30/month "coaching add-on" upsells once you are in. The price you see at checkout is the all-in price. For users tired of cafeteria-style telehealth where every screen reveals another upsell, this structure is a relief.
The downside: you cannot price-shop before committing your time to the intake form. If you are doing budget research across five platforms in one afternoon, bmiMD is a black box at that stage of the funnel. That is structurally inferior to Embody's flat $149 or Peter MD's published $149-first / $249-quarterly Tirzepatide. We mention this because it shapes who fits this provider — see the "who should skip" section below.
Why we vetted bmiMD into the roster
Our editorial bar for adding a partner is not commission rate alone — we have rejected high-EPC offers from providers whose pricing structures or compliance posture we couldn't get comfortable with. Three things pushed bmiMD across the line:
- Largest member base in the roster. Even discounting the 80K+ figure for marketing inflation, the platform is clearly operating at scale that smaller competitors aren't. Scale matters for two reasons: it implies the fulfillment pipeline has been stress-tested, and it gives a wider distribution of patient outcomes for the physician team to reference when titrating doses.
- Highest conversion rate we have measured. 6.99% from our editorial traffic versus 3-5% category baseline. That is a real signal — it means the intake flow is competent, the landing-page copy matches consumer expectations, and the price-after-intake structure does not produce mass abandonment.
- No-insurance, no-hidden-fees pricing transparency. Once you are inside the quote, the all-inclusive structure is genuinely all-inclusive. We confirmed there are no per-consult upcharges, no required supplement bundles, no $30/month coaching add-ons.
The "Beauty & Cosmetics" Katalys category is unusual for a metabolic-medicine product — we note that for editorial transparency. The brand may be repositioning, or the categorization may reflect Katalys's network-side taxonomy decisions. It does not affect the medication being prescribed.
bmiMD pros (5)
- 1. Social-proof scale. 80,000+ self-reported member base and a 4.9-star marketing rating is the largest social-proof footprint in our reviewed roster. For users whose decision is anchored on "is this provider real and used by many people?" bmiMD answers that question more emphatically than any peer.
- 2. Mature operational scale. 80K-member operations have stress-tested their fulfillment, customer support, and physician workflows in a way that smaller competitors have not. Shipping reliability and prescription continuity tend to be better at scale.
- 3. UX-optimized intake flow. Our 6.99% editorial conversion rate is direct evidence that the intake experience matches consumer expectations and does not produce mass abandonment. That is a quiet but real quality signal.
- 4. Same active molecules as Wegovy and Zepbound. The compounded semaglutide and tirzepatide preparations contain the same active ingredients as the branded FDA-approved finished products. (See compounded medications notice below for the important caveat on what "same active molecule" does and does not mean.)
- 5. No insurance hassle. The cash-pay subscription model means no preauthorization, no formulary fights, no reauthorization paperwork every 90 days. For users without commercial coverage of GLP-1s — which is most users right now — this is meaningful operational simplicity.
bmiMD cons (3)
- 1. Opaque pricing pre-intake. The personalized-pricing model means you cannot price-shop without filling out the intake questionnaire. If you are doing comparison research across five platforms in one afternoon, bmiMD is a black box at that stage. Embody's $149 flat, SkinnyRx's $179 first month, and Peter MD's published Tirzepatide pricing are structurally easier to compare.
- 2. Affiliate-network category is awkward. Katalys lists bmiMD under "Beauty & Cosmetics" rather than telehealth or weight management. This is taxonomy noise rather than a product flaw, but it is worth noting for transparency, and it may indicate the brand is in a positioning transition.
- 3. Not a multi-vertical hormone clinic. bmiMD focuses on GLP-1 weight management. If you want testosterone replacement therapy (TRT) alongside your GLP-1, or Sermorelin, NAD+, and B12 stacked under one clinical relationship, Peter MD is structurally a better fit. bmiMD does one thing and does it at scale.
Important: compounded medications notice
Per bmiMD's own disclaimer: the compounded semaglutide and compounded tirzepatide preparations dispensed by bmiMD are NOT FDA-approved as finished products.
What that means in practice: the active ingredients (semaglutide, tirzepatide) are the same molecules used in Wegovy, Ozempic, Zepbound, and Mounjaro. However, the compounded preparation as dispensed has not been reviewed by the FDA as a finished drug product. Compounded medications are legal when prepared by licensed 503A pharmacies for an individual patient — this is the same regulatory framework used by Eden, SkinnyRx, GobyMeds, and the majority of compounded-GLP-1 telehealth platforms — but the regulatory standard is different from FDA-approved branded products.
Sterility, potency, and batch-to-batch consistency depend on the compounding pharmacy fulfilling the prescription. We recommend asking which pharmacy fills your bmiMD prescription and requesting a Certificate of Analysis on the preparation. These are reasonable asks of any compounded-GLP-1 provider.
Who bmiMD is for (and who should skip)
Good fit if you...
- • Want a tested, established compounded-GLP-1 provider with a large existing member base
- • Make decisions partly based on social proof (large member counts, high marketing rating)
- • Prefer an all-inclusive structure — medication, telehealth, dietary guidance under one price — over cafeteria-style upsells
- • Are willing to complete an intake questionnaire to receive a personalized quote rather than seeing a hook price first
- • Do not have commercial insurance coverage of branded GLP-1s and prefer cash-pay simplicity
- • Want a single-purpose GLP-1 provider rather than a multi-vertical hormone clinic
Skip bmiMD if you...
- • Want the cheapest entry price published up front (Embody $149/mo flat or SkinnyRx $179 first month win on hook pricing)
- • Want a multi-vertical hormone clinic for stacked TRT + GLP-1 + Sermorelin + NAD+ (Peter MD is the structural pick)
- • Want pharmacy-disclosed transparency on every product page (Yucca Health leads the category here)
- • Want bundled coaching with weekly check-ins and a loss guarantee (SHED is the bundled-coaching pick)
- • Have strong commercial insurance coverage of Wegovy or Zepbound and prefer the FDA-approved branded products with copay assistance
- • Need to price-compare across five platforms in one afternoon (bmiMD's post-intake pricing makes this harder)
How bmiMD compares to our other reviewed partners
No single partner wins on every axis. The honest framing is trade-offs:
| Partner | GLP-1 entry price | Catalog scope | Best at |
|---|---|---|---|
| bmiMD | Personalized post-intake | Compounded sema + tirz (all-inclusive) | Scale, social proof, conversion (6.99%) |
| Peter MD | $149 first / $165–$249 ongoing | TRT, GLP-1, Sermorelin, NAD+, B12 | Men stacking hormones + weight loss |
| Embody | $149/mo flat | GLP-1 + GLP-1 chewable | Needle-averse / lowest ongoing |
| SkinnyRx | $179 first / $199–$249 | GLP-1 only | Cheapest 30-day test |
| Yucca Health | ~$200–$300/mo | GLP-1 (pharmacy disclosed) | Pharmacy transparency / Trustpilot 4.6 |
| SHED | $199–$299/mo | GLP-1 + supplements + coaching | Bundled coaching, 10% loss guarantee |
| Sprout Health | $250/mo | GLP-1 + NAD+ add-on | Longevity stack |
| System Labs | $229–$329/mo | GLP-1 + peptide catalog | Broad peptide stack (BPC-157, TB-500) |
| Sesame Care | $16 single consult | Marketplace, single appointments | Lowest commitment, no subscription |
| GobyMeds | $199–$349 + $25 coupon | GLP-1 menu (sema, tirz, low-dose) | Established brand + pricing transparency |
Eden Health, previously a recommended partner, is temporarily paused as of May 2026. We are not currently accepting referrals to Eden. Closest alternative for bundled-clinical-coaching is SHED.
Comparing bmiMD against others? Get the full PDF guide
11 providers ranked by price, pharmacy, and what each is best for. Emailed instantly.
Educational. Affiliate links. Not medical advice. No spam. Full disclosure
Ready to see your personalized bmiMD quote?
bmiMD's pricing is assigned after a brief intake questionnaire. The quote you receive is all-inclusive — medication, telehealth physician access, and dietary guidance bundled under one subscription. Verify your state of residence and current medications during intake before authorizing the subscription.
FTC disclosure: this is an affiliate link. We may earn a commission if you purchase, at no extra cost to you.
Start bmiMD intake →bmiMD FAQ
What is bmiMD?
bmiMD (Personalized Health RX) is a US telehealth platform focused on weight management through compounded GLP-1 medications — compounded semaglutide and compounded tirzepatide, the same active molecules as Wegovy and Zepbound respectively. The program bundles medication, telehealth physician access, and dietary guidance into a single all-inclusive personalized subscription. bmiMD reports 80,000+ members and a 4.9-star average rating on its own platform.
How much does bmiMD cost in 2026?
bmiMD does not publish a fixed entry price. Pricing is personalized and assigned after the intake questionnaire. The subscription is all-inclusive: medication, telehealth consultation, and dietary guidance bundled together with no separate add-on fees. Confirm the quoted price at checkout before authorizing the charge.
Are bmiMD's medications the same as Wegovy or Zepbound?
The active molecules are the same — semaglutide (the Wegovy/Ozempic active) and tirzepatide (the Zepbound/Mounjaro active). However, bmiMD dispenses these as compounded preparations from 503A pharmacies, not as the FDA-approved finished products. Compounded medications are legal but are NOT FDA-approved as finished products. Sterility and potency depend on the compounding pharmacy. Per bmiMD's own disclaimer, the compounded medications are not FDA-approved as finished products.
Is the 80,000-member claim verified?
The 80,000+ figure is bmiMD's published self-reported number. We have not independently audited it and have no way to verify it from outside. We report it as a marketing claim, which is the accurate framing for any consumer reviewing the platform. The 4.9-star rating and the 15% body-fat-loss outcome cited in some marketing materials are similarly bmiMD's published claims, and individual results vary.
What payment options does bmiMD accept?
bmiMD operates a no-insurance cash-pay model. Standard credit card payment is supported. Insurance is not billed, and the subscription price you see at intake is the all-in cost with no hidden fees. Users with strong commercial insurance covering branded GLP-1s may find Wegovy or Zepbound cheaper after copay assistance, but availability has been constrained.
Can I switch from another GLP-1 provider to bmiMD?
Yes. Switching telehealth GLP-1 providers is common. The new platform's physician reviews your dose history at intake and continues you at the appropriate level rather than restarting at the lowest dose. Bring documentation of your current dose, prescribing physician, and any adverse events. Avoid extended gaps between prescriptions that could reset GI tolerance.
Is bmiMD legitimate?
bmiMD operates as a licensed telehealth platform with 503A compounding pharmacy fulfillment — the same general structure as SkinnyRx, GobyMeds, and most compounded-GLP-1 providers. As of May 2026 we are not aware of FDA warning letters specific to bmiMD. The 80,000-member figure and 4.9-star rating are bmiMD's published marketing data. Standard diligence: verify clinician licensure in your state at intake, ask which compounding pharmacy will fill your prescription, and request a Certificate of Analysis on the preparation.
Who should NOT use bmiMD?
Skip bmiMD if you want a published low entry price (Embody $149/mo flat or SkinnyRx $179 first month — bmiMD does not publish hook pricing), if you want a multi-vertical hormone clinic stacking TRT + GLP-1 + Sermorelin (Peter MD is better), if you want pharmacy-disclosed transparency on every product page (Yucca Health leads), or if you have strong commercial insurance coverage for FDA-approved Wegovy or Zepbound and prefer those branded products.
Final verdict
Editorial rating: 4.5 / 5. bmiMD is the largest-footprint compounded-GLP-1 telehealth in our reviewed roster, with the highest editorial conversion rate (6.99%) and a self-reported 80,000+ member base. For users whose decision is anchored on tested-and-established scale rather than the lowest entry price, bmiMD is a defensible pick. The all-inclusive structure — medication, telehealth, dietary guidance under one price — is genuinely convenient and reduces decision friction.
The two structural caveats are real. First, pricing is opaque before intake — you cannot price-shop without filling out the questionnaire, which is structurally inferior to Embody's $149-flat or Peter MD's published Tirzepatide pricing for comparison shoppers. Second, the compounded medications are NOT FDA-approved as finished products (per bmiMD's own disclaimer); sterility and potency depend on the 503A compounding pharmacy.
What we like: Genuine operational scale. Highest conversion rate in our roster. All-inclusive bundle removes upsell fatigue. Same active molecules as Wegovy/Zepbound. No insurance hassles. Marketing claims (80K members, 4.9 stars, 15% body-fat loss) are published consistently — we report them as published per bmiMD's data.
What we'd improve: Publish a pricing range pre-intake to allow comparison shopping. Move out of the "Beauty & Cosmetics" Katalys category into telehealth/weight management for clearer brand positioning. Disclose the fulfilling 503A pharmacy on product pages (Yucca Health is the category leader on this transparency dimension).
FTC disclosure: We earn a commission when you sign up through our links, at no extra cost to you. This does not influence our editorial assessment.
Compare with our other provider reviews
Peter MD Review →
TRT + GLP-1 + Sermorelin + NAD+
Sprout Health Review →
GLP-1 + NAD+ longevity stack
Yucca Health Review →
Pharmacy-disclosed transparency
System Labs Review →
Multi-vertical peptide catalog
Sesame Care Review →
Marketplace, no subscription
⭐ See all reviews →
10 active partners side-by-side